Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates

Apollo Hospitals reported strong FY2026 results with consolidated revenue growing 15.7% to Rs 252,285 million and PAT surging 33.1% to Rs 20,027 million. Standalone revenue rose 13.7% to Rs 93,262 million with PAT up 15.1% to Rs 14,926 million. The Board recommended a final dividend of Rs 10 per share (200%), following an interim dividend of same amount already paid. Key leadership re-appointments include Dr Prathap C Reddy as Executive Chairman for 2 years and Ms Rama Bijapurkar as Independent Director for 5 years. Two significant corporate actions were approved: merger of Apollo Hospitals North Limited (wholly owned subsidiary) into the Company, and a transaction where Apollo Health and Lifestyle Limited will divest stakes in two subsidiaries to Kids Clinic India Limited (Cloudnine) for Rs 15,500 million enterprise value. Auditors Deloitte Haskins & Sells LLP issued unmodified opinions on both standalone and consolidated results.